Ranitidine Drugs (Zantac)
Effective April 1, 2020 the Food and Drug Administration requested the removal of ranitidine products (brand name Zantac) from the market. These popular over-the-counter products have been used as an antacid for reflux and other intestinal conditions for decades. The FDA on April 1, 2020 said:
“[I]t is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications
(commonly known by the brand name Zantac).”
For further information see: https://www.fda.gov/news-events/press-announcements/fda-requests-removal-all-ranitidine-products-zantac-market
If you or a loved one have used these products in the past have been diagnosed with cancer, contact the lawyers at Grossman Green PLLC to evaluate whether you may have a potential case.